2020 IPO
Acutus Medical Stock
Dedical technologies to treat complex cardiac arrhythmia
Sign up today and learn more about Acutus Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Acutus Medical Stock
Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists. Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, CA. Its products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.
Funding History
| August 2011 | $1.0M |
|---|---|
| September 2011 | $5.5M |
| August 2012 | $2.5M |
| August 2013 | $28.0M |
| September 2014 | $26.2M |
| March 2016 | $75.0M |
| June 2019 | $100M |
| June 2019 | $70.0M |
Management
Co-Founder,President & Chief Executive Officer
Randy Werneth
Director
Vince Burgess
Team Member
Shahzad Malik
Head Of Business Development and Market Development
Peter Elia
CTO
Grayadon Beatty
VP of Research and Development
Tim Corvi
Chief Commercial Officer
Michael Iversen
COO
Dave Brengle
VP R&D
Tim Corvi
EquityZen Recognized As:
